Intraoperative Neurophysiologic Monitoring (Ionm) Or Intraoperative Neuromonitoring Is A Technique To Reduce The Risk Of Neurological Deficits After Operations That Involve The Nervous System. Ionm Has Evolved In The Last Two Decades; It Utilizes Recordings Of Electrical Potentials From The Nervous System During Surgical Procedures. The Use Of Neuromonitoring Offers An Opportunity To Detect Injuries Before They Become So Severe That They Cause Deficits After The Operation. Therefore, With The Introduction Of Ionm, The Risk Of Debilitating Deficits Such As Muscle Weakness, Paralysis, Hearing Loss, And Other Loss Of Normal Body Functions Are Reduced. Research Beam Model: Research Beam Product ID: 1237757 5370 USD New
Intraoperative Neuromonitoring Market by Products & Services (Systems, Accessories, and Services) Source Type (Insourced Monitoring and Outsourced Monitoring), Application (Spinal Surgery, Neurosurgery, Vascular Surgery, ENT Surgery, and Orthopedic Surgery), Modality (Motor Evoked Potentials (MEPs), Somatosensory Evoked Potentials (SSEPs), Electroencephalography (EEG), Electromyography (EMG), Brainstem Auditory Evoked Potentials (BAEPs), and Visual Evoked Potentials (VEPs)) and End User (Hospitals and Ambulatory Surgical Centers (ASCs)) - Global Opportunity Analysis and Industry Forecast, 2014-2022
 

Intraoperative Neuromonitoring Market by Products & Services (Systems, Accessories, and Services) Source Type (Insourced Monitoring and Outsourced Monitoring), Application (Spinal Surgery, Neurosurgery, Vascular Surgery, ENT Surgery, and Orthopedic Surgery), Modality (Motor Evoked Potentials (MEPs), Somatosensory Evoked Potentials (SSEPs), Electroencephalography (EEG), Electromyography (EMG), Brainstem Auditory Evoked Potentials (BAEPs), and Visual Evoked Potentials (VEPs)) and End User (Hospitals and Ambulatory Surgical Centers (ASCs)) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Intraoperative Neuromonitoring Market by Products & Services (Systems, Accessories, and Services) Source Type (Insourced Monitoring and Outsourced Mon

Category : Medical Devices
Published On : February  2017
Pages : 240

request-discount


TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

Intraoperative Neurophysiologic Monitoring (Ionm) Or Intraoperative Neuromonitoring Is A Technique To Reduce The Risk Of Neurological Deficits After Operations That Involve The Nervous System. Ionm Has Evolved In The Last Two Decades; It Utilizes Recordings Of Electrical Potentials From The Nervous System During Surgical Procedures. The Use Of Neuromonitoring Offers An Opportunity To Detect Injuries Before They Become So Severe That They Cause Deficits After The Operation. Therefore, With The Introduction Of Ionm, The Risk Of Debilitating Deficits Such As Muscle Weakness, Paralysis, Hearing Loss, And Other Loss Of Normal Body Functions Are Reduced.

Ageing Population, Increase In The Number Of Surgical Procedures, Increased Awareness Regarding Benefits Of Ionm In Developed Regions, And Risk Management Through Ionm During Complex Surgeries Drive The Market. However, Low Awareness Of Ionm In Developing Nations And Dearth Of Skilled Professionals Hamper The Growth. Conversely, Applications Of Ionm In Different Surgeries And Growth Opportunities In The Emerging Economies Of The Asia-Pacific And Lamea Regions Are Expected To Provide Several Opportunities For Market Growth During The Forecast Period.

The Report Segments The Market Based On Products & Services, Source Type, Application, Modality, End User, And Region. Based On Products & Services, The Market Is Segmented Into Systems, Accessories And Services. Based On Source Type, The Market Is Bifurcated Into Insourced And Outsourced Monitoring. The End-User Segment Is Categorized Into Hospitals And Ambulatory Surgical Centers (Ascs). Ionm Finds Its Application In Spinal Surgery, Neurosurgery, Vascular Surgery, Ent Surgery, Orthopedic Surgery, And Other Surgeries Related To The Central Or Peripheral Nervous System. Ionm Modalities Include Motor Evoked Potentials (Meps), Somatosensory Evoked Potentials (Sseps), Electroencephalography (Eeg), Electromyography (Emg), Brainstem Auditory Evoked Potentials (Baeps) And Visual Evoked Potentials (Veps). Based On Region, The Market Is Analyzed Across North America (U.S., Canada, And Mexico), Europe (Germany, France, Italy, Uk, Spain, And Rest Of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, And Rest Of Asia-Pacific), And Lamea (Brazil, South Africa, Saudi Arabia, And Rest Of Lamea).

Key Players Operating In The Global Intraoperative Neuromonitoring Market Include Medtronic Plc, Nuvasive, Inc., Computational Diagnostics, Inc., Specialtycare, Natus Medical Incorporated., Intranerve, Llc, Inomed Medizintechnik Gmbh, Accuratemonitoring Llc, Nihon Kohden Corporation, And Day One Medical, Llc.

Key Benefits for Stakeholders

  • The Study Provides An In-Depth Analysis Of The Market With Current Trends And Future Estimations To Elucidate The Imminent Investment Pockets.
  • The Report Provides A Quantitative Analysis From 2014 To 2022, Which Is Expected To Enable The Stakeholders To Capitalize On Prevailing Market Opportunities.
  • Extensive Analysis By Application Helps Understand The Various Types Of Surgeries That May Require Ionm.
  • Competitive Intelligence Highlights The Business Practices Followed By Leading Players Across Various Regions.
  • Comprehensive Analysis Of All Geographical Regions Is Provided, Which Determines The Prevailing Opportunities In These Geographies.
  • Key Players Are Profiled In The Report And Their Strategies Are Analyzed Thoroughly, Which Helps Understand Competitive Outlook Of The Global Market.

Intraoperative Neuromonitoring Market Key Segments

By Products & Services

  • Systems
  • Accessories
  • Services

By Source Type

  • Insourced Monitoring
  • Outsourced Monitoring

By Application

  • Spinal Surgery
  • Neurosurgery
  • Vascular Surgery
  • Ent Surgery
  • Orthopedic Surgery
  • Other Surgeries

By Modality

  • Motor Evoked Potentials (Meps)
  • Somatosensory Evoked Potentials (Sseps)
  • Electroencephalography (Eeg)
  • Electromyography (Emg)
  • Brainstem Auditory Evoked Potentials (Baeps)
  • Visual Evoked Potentials (Veps)

By End User

  • Hospitals
  • Ambulatory Surgical Centers (Ascs)

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • Uk
    • France
    • Italy
    • Spain
    • Rest Of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest Of Asia-Pacific
  • Lamea
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest Of Lamea

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.2.1. Competitive intelligence of companies and their strategies

3.3. PLAYER POSITIONING, 2015
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Growing geriatric population
3.4.1.2. Increasing prevalence of chronic disorders
3.4.1.3. Applications of IONM in different surgeries
3.4.1.4. Risk management through IONM during complex surgeries

3.4.2. Restraints

3.4.2.1. Low awareness of IONM in developing nations
3.4.2.2. Dearth of skilled professionals

3.4.3. Opportunities

3.4.3.1. Increasing medical tourism
3.4.3.2. Growth opportunities in the emerging economies

3.4.4. Impact analysis

3.5. CLINICAL TRIALS
3.6. REIMBURSEMENT SCENARIO IN U.S.

CHAPTER 4 INTRAOPERATIVE NEUROMONITORING MARKET BY PRODUCTS & SERVICES

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. SYSTEMS

4.2.1. Market size and forecast

4.3. ACCESSORIES

4.3.1. Market size and forecast

4.4. SERVICES

4.4.1. Market size and forecast

CHAPTER 5 INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. INSOURCED MONITORING

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast

5.3. OUTSOURCED MONITORING

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast

CHAPTER 6 INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. SOMATOSENSORY EVOKED POTENTIALS (SSEPS)

6.2.1. Market size and forecast

6.3. ELECTROMYOGRAPHY (EMG)

6.3.1. Market size and forecast

6.4. ELECTROENCEPHALOGRAPHY (EEG)

6.4.1. Market size and forecast

6.5. BRAINSTEM AUDITORY EVOKED POTENTIALS (BAEPS)

6.5.1. Market size and forecast

6.6. MOTOR EVOKED POTENTIALS (MEPS)

6.6.1. Market size and forecast

6.7. VISUAL EVOKED POTENTIALS (VEPS)

6.7.1. Market size and forecast

CHAPTER 7 INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. SPINAL SURGERY

7.2.1. Market size and forecast

7.3. ENT SURGERY

7.3.1. Market size and forecast

7.4. NEUROSURGERY

7.4.1. Market size and forecast

7.5. VASCULAR SURGERY

7.5.1. Market size and forecast

7.6. ORTHOPEDIC SURGERY

7.6.1. Market size and forecast

7.7. OTHER SURGERIES

7.7.1. Market size and forecast

CHAPTER 8 INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. HOSPITALS

8.2.1. Market size and forecast

8.3. AMBULATORY SURGICAL CENTERS (ASCS)

8.3.1. Market size and forecast

CHAPTER 9 INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION

9.1. OVERVIEW

9.1.1. Market size and forecast

9.2. NORTH AMERICA

9.2.1. Key market trends
9.2.2. Key growth factors and opportunities
9.2.3. Market size and forecast
9.2.4. U.S.
9.2.5. Canada
9.2.6. Mexico

9.3. EUROPE

9.3.1. Key market trends
9.3.2. Key growth factors and opportunities
9.3.3. Market size and forecast
9.3.4. Germany
9.3.5. France
9.3.6. UK
9.3.7. Italy
9.3.8. Spain
9.3.9. Rest of Europe

9.4. ASIA-PACIFIC

9.4.1. Key market trends
9.4.2. Key growth factors and opportunities
9.4.3. Market size and forecast
9.4.4. Japan
9.4.5. China
9.4.6. India
9.4.7. South Korea
9.4.8. Australia
9.4.9. Rest of Asia-Pacific

9.5. LAMEA

9.5.1. Key market trends
9.5.2. Key growth factors and opportunities
9.5.3. Market size and forecast
9.5.4. Brazil
9.5.5. South Africa
9.5.6. Saudi Arabia
9.5.7. Rest of LAMEA

CHAPTER 10 COMPANY PROFILES

10.1. ACCURATE MONITORING, LLC

10.1.1. Company overview
10.1.2. Company snapshot
10.1.3. Key strategic moves & developments

10.2. COMPUTATIONAL DIAGNOSTICS, INC.

10.2.1. Company overview
10.2.2. Company snapshot
10.2.3. Key strategic moves & developments

10.3. INOMED MEDIZINTECHNIK GMBH

10.3.1. Company overview
10.3.2. Company snapshot
10.3.3. Operating business segments
10.3.4. Key strategic moves & developments

10.4. INTRANERVE, LLC

10.4.1. Company overview
10.4.2. Company snapshot
10.4.3. Key strategic moves & developments

10.5. MEDTRONIC PLC

10.5.1. Company overview
10.5.2. Company snapshot
10.5.3. Operating business segments
10.5.4. Business performance
10.5.5. Key strategic moves & developments

10.6. MOBERG RESEARCH, INC

10.6.1. Company overview
10.6.2. Company snapshot
10.6.3. Operating business segments
10.6.4. Key strategic moves & developments

10.7. NATUS MEDICAL INCORPORATED.

10.7.1. Company overview
10.7.2. Company snapshot
10.7.3. Operating business segments
10.7.4. Business performance
10.7.5. Key strategic moves & developments

10.8. NIHON KOHDEN CORPORATION

10.8.1. Company overview
10.8.2. Company snapshot
10.8.3. Operating business segments
10.8.4. Business performance
10.8.5. Key strategic moves & developments

10.9. NUVASIVE, INC.

10.9.1. Company overview
10.9.2. Company snapshot
10.9.3. Operating business segments
10.9.4. Business performance
10.9.5. Key strategic moves & developments

10.10. SPECIALTYCARE

10.10.1. Company overview
10.10.2. Company snapshot
10.10.4. Key strategic moves & developments

LIST OF TABLES

TABLE 1. CLINICAL TRIALS IN IONM MARKET
TABLE 2. COMPLETED CLINICAL TRIALS IN INTRAOPERATIVE NEUROMONITORING MARKET
TABLE 3. BASE (PRIMARY) CODES FOR IONM MODALITIES
TABLE 4. HOSPITAL INPATIENT CODES
TABLE 5. GLOBAL IONM MARKET, BY PRODUCTS & SERVICES ($MILLION), 2014-2022
TABLE 6. GLOBAL INTRAOPERATIVE NEUROMONITORING SYSTEMS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 7. GLOBAL INTRAOPERATIVE NEUROMONITORING ACCESSORIES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 8. GLOBAL INTRAOPERATIVE NEUROMONITORING SERVICES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 9. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE ($MILLION), 2014-2022
TABLE 10. GLOBAL INTRAOPERATIVE NEUROMONITORING SOURCE TYPE MARKET, BY REGION ($MILLION), 2014-2022
TABLE 11. GLOBAL INSOURCED INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
TABLE 12. GLOBAL OUTSOURCED INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
TABLE 13. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY ($MILLION), 2014-2022
TABLE 14. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION ($MILLION), 2014-2022
TABLE 15. GLOBAL INTRAOPERATIVE NEUROMONITORING APPLICATIONS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 16. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR SPINAL SURGERY, BY REGION ($MILLION), 2014-2022
TABLE 17. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR ENT SURGERY, BY REGION ($MILLION), 2014-2022
TABLE 18. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR NEUROSURGERY, BY REGION ($MILLION), 2014-2022
TABLE 19. GLOBAL INTRAOPRATIVE NEUROMONITORING FOR VASCULAR SURGERY, BY REGION ($MILLION), 2014-2022
TABLE 20. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR ORTHOPEDIC SURGERY, BY REGION ($MILLION), 2014-2022
TABLE 21. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR OTHER SURGERIES, BY REGION ($MILLION), 2014-2022
TABLE 22. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER ($MILLION), 2014-2022
TABLE 23. HOSPITALS INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
TABLE 24. AMBULATORY SURGICAL CENTERS (ASCS) INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
TABLE 25. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
TABLE 26. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 27. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
TABLE 28. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 29. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 30. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
TABLE 31. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 32. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 33. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
TABLE 34. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 35. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 36. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
TABLE 37. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 38. ACCURATE MONITORING: COMPANY SNAPSHOT
TABLE 39. COMPUTATIONAL DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 40. INOMED: COMPANY SNAPSHOT
TABLE 41. INOMED: OPERATING SEGMENTS
TABLE 42. INTRANERVE: COMPANY SNAPSHOT
TABLE 44. MEDTRONIC: COMPANY SNAPSHOT
TABLE 45. MEDTRONIC: OPERATING SEGMENTS
TABLE 46. MOBERG RESEARCH: COMPANY SNAPSHOT
TABLE 47. MOBERG RESEARCH: OPERATING SEGMENTS
TABLE 48. NATUS MEDICAL: COMPANY SNAPSHOT
TABLE 49. NATUS MEDICAL: OPERATING SEGMENTS
TABLE 50. NIHON KOHDEN: COMPANY SNAPSHOT
TABLE 51. NIHON KOHDEN: OPERATING SEGMENTS
TABLE 52. NUVASIVE: COMPANY SNAPSHOT
TABLE 53. NUVASIVE: OPERATING SEGMENTS
TABLE 54. SPECIALTYCARE: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 1. INTRAOPERATIVE NEUROMONITORING MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 8. PLAYER POSITIONING, 2015
FIGURE 9. IMPACT ANALYSIS: INTRAOPERATIVE NEUROMONITORING MARKET
FIGURE 10. GLOBAL IONM MARKET, BY PRODUCTS & SERVICES ($MILLION), 2014-2022
FIGURE 11. GLOBAL INTRAOPERATIVE NEUROMONITORING SYSTEMS MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 12. GLOBAL INTRAOPERATIVE NEUROMONITORING ACCESSORIES MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 13. GLOBAL INTRAOPERATIVE NEUROMONITORING SERVICES MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 14. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE ($MILLION), 2014-2022
FIGURE 15. GLOBAL INTRAOPERATIVE NEUROMONITORING SOURCE TYPE MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 16. GLOBAL INSOURCED INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 17. GLOBAL OUTSOURCED INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 18. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY ($MILLION), 2014-2022
FIGURE 19. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET FOR SSEPS ($MILLION), 2014-2022
FIGURE 20. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET FOR EMG ($MILLION), 2014-2022
FIGURE 21. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET FOR EEG ($MILLION), 2014-2022
FIGURE 22. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET FOR BAEPS ($MILLION), 2014-2022
FIGURE 23. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET FOR MEPS ($MILLION), 2014-2022
FIGURE 24. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET FOR VEPS ($MILLION), 2014-2022
FIGURE 25. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION ($MILLION), 2014-2022
FIGURE 26. GLOBAL INTRAOPERATIVE NEUROMONITORING APPLICATIONS MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 27. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR SPINAL SURGERY, BY REGION ($MILLION), 2014-2022
FIGURE 28. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR ENT SURGERY, BY REGION ($MILLION), 2014-2022
FIGURE 29. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR NEUROSURGERY, BY REGION ($MILLION), 2014-2022
FIGURE 30. GLOBAL INTRAOPRATIVE NEUROMONITORING FOR VASCULAR SURGERY, BY REGION ($MILLION), 2014-2022
FIGURE 31. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR ORTHOPEDIC SURGERY, BY REGION ($MILLION), 2014-2022
FIGURE 32. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR OTHER SURGERIES, BY REGION ($MILLION), 2014-2022
FIGURE 33. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER ($MILLION), 2014-2022
FIGURE 34. HOSPITALS & CLINICS INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 35. AMBULATORY SURGICAL CENTERS (ASCS) INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 36. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 37. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 38. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
FIGURE 39. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
FIGURE 40. U.S. IONM MARKET ($MILLION), 2014-2022
FIGURE 41. CANADA IONM MARKET ($MILLION), 2014-2022
FIGURE 42. MEXICO IONM MARKET ($MILLION), 2014-2022
FIGURE 43. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 44. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
FIGURE 45. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
FIGURE 46. GERMANY IONM MARKET ($MILLION), 2014-2022
FIGURE 47. FRANCE IONM MARKET ($MILLION), 2014-2022
FIGURE 48. UK IONM MARKET ($MILLION), 2014-2022
FIGURE 49. ITALY IONM MARKET ($MILLION), 2014-2022
FIGURE 50. SPAIN IONM MARKET ($MILLION), 2014-2022
FIGURE 51. REST OF EUROPE IONM MARKET ($MILLION), 2014-2022
FIGURE 52. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 53. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
FIGURE 54. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
FIGURE 55. JAPAN IONM MARKET ($MILLION), 2014-2022
FIGURE 56. CHINA IONM MARKET ($MILLION), 2014-2022
FIGURE 57. INDIA IONM MARKET ($MILLION), 2014-2022
FIGURE 58. SOUTH KOREA IONM MARKET ($MILLION), 2014-2022
FIGURE 59. AUSTRALIA IONM MARKET ($MILLION), 2014-2022
FIGURE 60. REST OF ASIA-PACIFIC IONM MARKET ($MILLION), 2014-2022
FIGURE 61. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 62. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
FIGURE 63. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
FIGURE 64. BRAZIL IONM MARKET ($MILLION), 2014-2022
FIGURE 65. SOUTH AFRICA IONM MARKET ($MILLION), 2014-2022
FIGURE 66. SAUDI ARABIA IONM MARKET ($MILLION), 2014-2022
FIGURE 67. REST OF LAMEA IONM MARKET ($MILLION), 2014-2022
FIGURE 68. MEDTRONIC: NET SALES, 2013-2015 ($MILLION)
FIGURE 69. MEDTRONIC: NET SALES, BY SEGMENT, 2015 ($MILLION)
FIGURE 70. MEDTRONIC: NET SALES, BY GEOGRAPHY, 2015 ($MILLION)
FIGURE 71. NATUS MEDICAL: NET SALES, 2013-2015 ($MILLION)
FIGURE 72. NATUS MEDICAL: NET SALES, BY SEGMENT, 2015 ($MILLION)
FIGURE 73. NATUS MEDICAL: NET SALES, BY GEOGRAPHY, 2015 ($MILLION)
FIGURE 74. NIHON KOHDEN: NET SALES, 2013-2015 ($MILLION)
FIGURE 75. NIHON KOHDEN: NET SALES, BY SEGMENT, 2015 ($MILLION)
FIGURE 76. NIHON KOHDEN: NET SALES, BY GEOGRAPHY, 2015 ($MILLION)
FIGURE 77. NUVASIVE: NET SALES, 2013-2015 ($MILLION)
FIGURE 78. NUVASIVE: NET SALES, BY SEGMENT, 2015 ($MILLION)
FIGURE 79. NUVASIVE: NET SALES, BY GEOGRAPHY, 2015 ($MILLION)

Enquiry Before Buy